Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Csikos Csaba

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2021-2025

2025

Ogum, A., Barna, S., Szoboszlai, Z., Krizsán, Á. K., Renaud, J., Mitchell, T., Budai, Á., Ország, G., Csikos, C., Garai, I.: Coronary Flow Reserve Evaluation with a Novel Multi-pinhole Collimator on Triple-Na-I-detector SPECT/CT in Coronary Artery Disease: a Pilot Study.
EANM Innovation 1, S234, 2025.

doi DEA

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T., Szoboszlai, Z., Csikos, C., Váradi, B., Trencsényi, G., Tircsó, G., Garai, I.: HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.
Pathol. Oncol. Res. 31, 1-12, (article identifier: 1611999), 2025.

doi DEA WoS Scopus

Journal metrics:

Q3 Cancer Research (2024)

Q2 Medicine (miscellaneous) (2024)

Q2 Oncology (2024)

Q2 Pathology and Forensic Medicine (2024)

Einieh, M., Barna, S., Budai, Á., Ország, G., Csikos, C., Garai, I.: Integrating Whole-Body Bone SPECT and AI-Synthetic CT in the Evaluation of Non-Oncologic Disorders.
EANM Innovation. 1, S370-S371, 2025.

doi DEA

Csikos, C., Varga, A., Hascsi, Z., Molnár, S., Krasznai, Z. T., Garai, I.: PET/CT-Guided Patient Selection for Secondary Cytoreduction in Recurrent Ovarian Cancer.
EANM Innovation. 1, S573, 2025.

doi DEA

Ngo, M. T., Nagy, T., Szoboszlai, Z., Csikos, C., Dénes, N., Furka, A., Trencsényi, G., Garai, I.: The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: a Preliminary Report.
In Vivo. 39 (1), 160-171, 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q3 Cancer Research (2024)

Q2 Medicine (miscellaneous) (2024)

Q3 Pharmacology (2024)

2024

Ngo, M. T., Vágner, A., Nagy, G., Ország, G., Nagy, T. M., Csikos, C., Váradi, B., Sajtos, G. Z., Kapus, I., Szoboszlai, Z., Szikra, D. P., Trencsényi, G., Tircsó, G., Garai, I.: [52 Mn]Mn-BPPA-Trastuzumab: A Promising HER2-Specific PET Radiotracer.
J. Med. Chem. 67 (10), 8261-8270, 2024.

doi DEA WoS Scopus

Journal metrics:

D1 Drug Discovery

Q1 Molecular Medicine

Csikos, C., Barna, S., Kovács, Á., Czina, P., Budai, Á., Szolikova, M., Nagy, I. G., Husztik, B., Kiszler, G., Garai, I.: AI-Based Noise-Reduction Filter for Whole-Body Planar Bone Scintigraphy Reliably Improves Low-Count Images.
Diagnostics. 14 (23), 1-11, (article identifier: 2686), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

Q2 Internal Medicine

Barna, S., Szolikova, M., Csikos, C., Török, J., Husztik, B., Varga, J., Kovács, Á., Garai, I.: Artificial Intelligence Based CT-free Attenuation Correction in Adolescent and Young Adult Mandibular Condylar Hyperplasia Patients.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S778-S779, 2024.

doi DEA

Képes, Z., Hegedűs, É., Sass, T., Csikos, C., Péli-Szabó, J., Szugyiczki, V., Hajdu, I., Kertész, I., Opposits, G., Imrek, J., Balkay, L., Kálmán, F. K., Trencsényi, G.: Concomitant [18F]F-FAZA and [18F]F-FDG Imaging of Gynecological Cancer Xenografts: insight Into Tumor Hypoxia.
In Vivo. 38 (2), 574-586, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Pharmacology

10.

Képes, Z., Arató, V. Z., Csikos, C., Hegedűs, É., Esze, R., Nagy, T., Jószai, I., Emri, M., Kertész, I., Trencsényi, G.: In Vivo Evaluation of Brain [18F]F-FDG Uptake Pattern Under Different Anaesthesia Protocols.
In Vivo. 38 (2), 587-597, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q3 Pharmacology

11.

Csikos, C., Czina, P., Molnár, S., Kovács, A. R., Garai, I., Krasznai, Z. T.: Predicting Complete Cytoreduction with Preoperative [18F]FDG PET/CT in Patients with Ovarian Cancer: a Systematic Review and Meta-Analysis.
Diagnostics. 14 (16), 1-14, (article identifier: 1740), 2024.

doi DEA Scopus

Journal metrics:

Q2 Clinical Biochemistry

Q2 Internal Medicine

12.

Trencsényi, G., Csikos, C., Képes, Z.: Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Int. J. Mol. Sci. 25 (1), 1-30, (article identifier: 664), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

D1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

13.

Csikos, C., Barna, S., Kovács, Á., Budai, Á., Szolikova, M., Nagy, I. G., Husztik, B., Kiszler, G., Garai, I.: Validation of an AI-Based Noise Reduction Filter on Bone Scan Images.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S787, 2024.

doi DEA WoS

2023

14.

Csikos, C., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Gyuricza, B., Arató, V. Z., Kárpáti, L., Mándity, I. M., Bruchertseifer, F., Halmos, G., Szikra, D. P., Trencsényi, G.: Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Int. J. Pharm. 644, 1-9, (article identifier: 123344), 2023.

doi DEA Scopus

Journal metrics:

Q1 Pharmaceutical Science

15.

Csikos, C., Vágner, A., Nagy, G., Kálmán-Szabó, I., Péli-Szabó, J., Ngo, M. T., Szoboszlai, Z., Szikra, D. P., Krasznai, Z. T., Trencsényi, G., Garai, I.: In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Diagnostics. 13 (2), 236-, 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Clinical Biochemistry

2021

16.

Kiss, A., Csikos, C., Regdon, Z., Polgár, Z., Virág, L., Hegedűs, C.: NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Int. J. Mol. Sci. 22 (16), 1-17, (article identifier: 8869), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy